Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Th17 cells: A prognostic marker for MS rebound after natalizumab cessation?
Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.
[Results of a comparative clinical trial of the Russian Β - interferon-1b bioanalogue (infibeta)].
NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels.
Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging
The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart.
Impact of sleep disorder treatment on fatigue in multiple sclerosis.
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS) (INSPIRE)
TGFβ Signaling Regulates the Timing of CNS Myelination by Modulating Oligodendrocyte Progenitor Cell Cycle Exit through SMAD3/4/FoxO1/Sp1.
Toxicity of Teriflunomide in Aryl Hydrocarbon Receptor Deficient Mice.
Minocycline inhibits antigen processing for presentation to human T cells: additive inhibition with chloroquine at therapeutic concentrations.
LETHAL MULTIPLE SCLEROSIS RELAPSE AFTER NATALIZUMAB WITHDRAWAL.
Functional effects of the antigen glatiramer acetate are complex and tightly associated with its composition.
Arzerra
Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: Differential expression of neurotrophic and gliotrophic factors.
Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases.
[Neuromyelitis optica following thymectomy with severe spinal cord atrophy after frequent relapses for 30 years].
Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration.
RILUTEK®
Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans.
Testing for urinary tract colonisation before high-dose corticosteroid treatment in acute multiple sclerosis relapses: prospective algorithm validation.
The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain.
Effects of prophylactic and therapeutic teriflunomide in transcranial magnetic stimulation-induced motor-evoked potentials in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.
Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI.

Pages